HIM
MNTA

Hillsdale Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Hillsdale Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-24,400
Closed -$812K – 688
2020
Q2 		$812K Buy
+24,400
New +$777K 0.07% 211

Other funds holding MNTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Hillsdale Investment Management's MNTA Position: Q3 2020 in Review

Hillsdale Investment Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 24,400 shares — an estimated $812K sold.

Hillsdale Investment Management first reported a position in MNTA in Q2 2020 and held it in 1 quarter. The position peaked at $812K in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Hillsdale Investment Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Hillsdale Investment Management sold 24,400 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $812K.
  • Hillsdale Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Hillsdale Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $812K in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Hillsdale Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.